Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Farmacosmo SpA's Net Income (Continuing Operations) for the
six
months ended in Dec. 2025 was €-1.69 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2025 was €-4.60 Mil.
Farmacosmo SpA (MIL:COSMO) Net Income (Continuing Operations) Explanation
Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.
Farmacosmo SpA Net Income (Continuing Operations) Related Terms
Farmacosmo SpA Net Income (Continuing Operations) Historical Data
* Premium members only.
The historical data trend for Farmacosmo SpA's Net Income (Continuing Operations) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Farmacosmo SpA Net Income (Continuing Operations) Chart
Farmacosmo SpA Net Income (Continuing Operations) Calculation
Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.
Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-4.60 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Income (Continuing Operations) of €-4.60 Mil mean?
Farmacosmo SpA (MIL:COSMO) has a Net Income (Continuing Operations) of €-4.60 Mil as of Dec. 2025. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Farmacosmo SpA and its competitors.
Is Farmacosmo SpA's Net Income (Continuing Operations) too high?
Farmacosmo SpA's current Net Income (Continuing Operations) is €-4.60 Mil. Overall, Farmacosmo SpA has a GF Score™ of 36/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Farmacosmo SpA's Net Income (Continuing Operations) compare to competitors?
Farmacosmo SpA's Net Income (Continuing Operations) of €-4.60 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income (Continuing Operations) for a Healthcare Providers & Services company?
A good Net Income (Continuing Operations) depends on the Healthcare Providers & Services industry context. However, Net Income (Continuing Operations) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income (Continuing Operations) mean?
A high Net Income (Continuing Operations) can signal that a stock is expensive relative to its fundamentals. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Farmacosmo SpA and its competitors. Farmacosmo SpA's current Net Income (Continuing Operations) is €-4.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farmacosmo SpA stock overvalued right now?
Based on GuruFocus' analysis, Farmacosmo SpA (MIL:COSMO) is currently considered Possible Value Trap. The stock's GF Value™ is €0.79, compared to a current price of €0.49 — trading 38.4% below its estimated fair value. The current Net Income (Continuing Operations) is €-4.60 Mil. Farmacosmo SpA's overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income (Continuing Operations) calculated?
Net Income (Continuing Operations) is calculated from a company's financial statements. For Farmacosmo SpA (MIL:COSMO), the current Net Income (Continuing Operations) is €-4.60 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Farmacosmo SpA (MIL:COSMO) Overvalued in 2026?
Based on GuruFocus' analysis, Farmacosmo SpA stock appears to be undervalued.
The current stock price of €0.49 is trading 38.4% below its estimated GF Value™ of €0.79.
GuruFocus considers Farmacosmo SpA to be Possible Value Trap.
Key valuation signals for MIL:COSMO:
Net Income (Continuing Operations): €-4.60 Mil
GF Value™: €0.79 vs. price of €0.49 (38.4% below fair value)
No single metric tells the full story. See the MIL:COSMO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Farmacosmo SpA is a wellness e-commerce company active in the Health, Pharma, and Wellness industry, authorized by the Italian Ministry of Health to sell pharmaceutical products online. In particular, the company offers parapharmaceutical products, vitamins and food supplements, dietetic products, medical devices, cosmetic products, personal hygiene products, hair care products, dental care products, skincare products, perfumes, home and baby items.
36GF Score
Get the complete analysis for MIL:COSMO
Net Income (Continuing Operations) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:COSMO has been successfully added to your 
